Partner
Mareesa has litigated numerous cases in a broad range of technologies including cosmetics, pharmaceutical products, manufacturing processes, biotechnology, polymers, semiconductor chips and packaging, kinesiotherapy devices, tunable lasers, mobile telephones, digital cameras, television and computer monitors, inkjet cartridges, printing plates, LED lighting, and automotive parts. She has also litigated cases involving design patents, trademarks, trade secrets, and trade dress claims.
Prior to rejoining the firm, Mareesa was a senior investigative attorney at the ITC and served as lead government counsel in a number of Section 337 cases before the ITC involving patents for mechanical, electrical, and consumer products. In addition, she has extensive technical experience in polymer processing through her previous employment with Mobil Chemical, Films Division where she worked as a R&D engineer and a process engineer.
Mareesa devotes a significant amount of time to pro bono matters. The Capital Pro Bono Honor Roll recently recognized her for those contributions. She has represented clients through the Washington Legal Clinic for the Homeless and has participated in Finnegan's criminal pro bono program, representing clients before the D.C. Superior Court. She now focuses her pro bono efforts on advocating for children with special education needs and has also led the effort at Finnegan to establish a formal special education program.
In addition to her patent practice at Finnegan, Mareesa has served as an adjunct professor at Howard University for six years, teaching patent law to engineering students. She also served as an adjunct professor at Howard University Law School for two years, where she taught patent law and patent policy courses. Mareesa was recognized by the National Law Journal as a Washington, D.C. "Rising Star."
Eli Lilly and Company v. Actavis Labs. UT Inc.
Represented Eli Lilly in patent litigation relating to Cialis®.
1:16-cv-01119, E.D. Va., Judges Nachmanoff, Trenga
Actelion Pharmaceuticals v. ICOS Corp.
Represented ICOS in Patent Trial and Appeal Board (PTAB) proceeding involving pharmaceutical formulation.
IPR2015-00561, -00562, PTAB, Judges Mitchell, Snedden, Yang
Eli Lilly and Company v. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
Represented Eli Lilly in an appeal from a PTAB decision in an IPR case.
IPR2014-00693, -00752, PTAB, Judges Green, Prats, Snedden
16-1547, Fed. Cir., Judges Bryson, Moore, Newman
Nippon Steel & Sumitomo Metal Corp. v. POSCO
Defended POSCO in a patent infringement action involving grain oriented steel.
2:12-cv-02429, D.N.J., Judges Cavanaugh, Chesler, Falk, Waldor
15-0112, Fed. Cir., Judges Dyk, Hughes, Newman
Arigna Technology Limited v. Volkswagen AG, et al.
337-TA-1267, ITC, Judge Bhattacharyya
IPR2021-01321, -01531, PTAB, Judges Baer, Fenick, Iftikhar
2:21-cv-00054; -00172, E.D. Tex., Judge Gilstrap
337-TA-1052; 337-TA-1073, ITC, Judges Lord, Pender, Bullock
IPR2017-01494, -01495, -01537, -01538, -01539, PTAB, Judges Droesch, Weiker, Hudalla
Articles
The Injury Requirement in ITC Section 337 Investigations The Injury Requirement in ITC Section 337 Investigations
July 2023
LexisNexis Practical GuidanceArticles
Working with OUII – The Staff Attorney’s Role and Practical Guidance on Interacting with the Staff Attorney Working with OUII – The Staff Attorney’s Role and Practical Guidance on Interacting with the Staff Attorney
July 2023
LexisNexis Practical GuidanceEvent
Day in the Life of a Patent Attorney Day in the Life of a Patent Attorney
July 12, 2023
Webniar
"Frederick has a sterling track record at the ITC, where she previously worked as a senior investigative attorney."
Intellectual Asset Management Patent 1000
“Mareesa Frederick is 'deeply familiar with the ITC practice and greatly contributes to the resolution of complicated problems, which occasionally arise during ITC proceedings.’”
Legal 500 United States
“Frederick, who also benefits from inside knowledge, recently won a rare complete victory on summary determination for REC Solar Holdings as respondent in a high-profile investigation involving solar cells.”
Intellectual Asset Management Patent 1000
"Frederick has a sterling track record at the ITC, where she previously worked as a senior investigative attorney."
Intellectual Asset Management Patent 1000
“Mareesa Frederick is 'deeply familiar with the ITC practice and greatly contributes to the resolution of complicated problems, which occasionally arise during ITC proceedings.’”
Legal 500 United States
“Frederick, who also benefits from inside knowledge, recently won a rare complete victory on summary determination for REC Solar Holdings as respondent in a high-profile investigation involving solar cells.”
Intellectual Asset Management Patent 1000
Press Release
Finnegan Receives Top Rankings from Intellectual Asset Management; 46 Attorneys Ranked Finnegan Receives Top Rankings from Intellectual Asset Management; 46 Attorneys Ranked
June 30, 2023
Intellectual Asset ManagementPress Release
The Legal 500 Ranks Finnegan a Top Tier Firm for 2023 The Legal 500 Ranks Finnegan a Top Tier Firm for 2023
June 12, 2023
The Legal 500Press Release
45 Finnegan Attorneys Recommended by Intellectual Asset Management; Firm Continues to Be Top Ranked 45 Finnegan Attorneys Recommended by Intellectual Asset Management; Firm Continues to Be Top Ranked
July 8, 2022
Intellectual Asset ManagementPress Release
Finnegan Continues to Be Ranked a Top Tier Law Firm in The Legal 500 United States 2022 Edition Finnegan Continues to Be Ranked a Top Tier Law Firm in The Legal 500 United States 2022 Edition
June 8, 2022
The Legal 500Commentary
It's Another First for ALJs at the International Trade Commission It's Another First for ALJs at the International Trade Commission
April 19, 2022
The National Law JournalCommentary
Minority in IP: Navigating a Lonely Road Minority in IP: Navigating a Lonely Road
March/April 2022
Washington LawyerDue to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.